Researchers have unlocked a key in a person's immune response that could halt the spread of cancer the body cannot see.

An enzyme called EZH2 has an unexpected role in driving aggressive tumor growth in treatment-resistant prostate cancers, according to a new study. The results could potentially lead to new therapies ...

An enzyme called EZH2 has an unexpected role in driving aggressive tumor growth in treatment-resistant prostate cancers, according to a new study by scientists at Weill Cornell Medicine.

As runners count down til Sunday's big race for the Marathon, the cause is driving some people to run 26.2 miles.

An enzyme called EZH2 has an unexpected role in driving aggressive tumor growth in treatment-resistant prostate cancers, ...

An enzyme called EZH2 has an unexpected role in driving aggressive tumor growth in treatment-resistant prostate cancers, according to a new study by ...

Researchers have identified a new role for the enzyme EZH2 in promoting the progression of aggressive, treatment-resistant ...

Graham Fulford has joined in delivering 138,000-strong petition calling on MPs to help save thousands of lives.

Furthermore, since TGF-β is associated with immune suppression in tumors, inhibiting this pathway could enhance immunotherapy effectiveness, a treatment with limited success against prostate cancer ...

Plants, fungi and bacteria produce a variety of bioactives that alter cell metabolism, sometimes to the point of cell death.

On International Men's Day, the Clinical Trials Arena team investigates three therapies being investigated in prostate cancer ...